State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Coverage – United States, 2008-2014
By American Lung Association | |
Proquest LLC |
To assess state
Comparing 2008 with 2014, 41 states made changes to the treatments they covered for at least some plans or populations, with 19 states adding treatments to coverage without removing any treatments from coverage, eight states removing treatments from coverage without adding any treatments to coverage, and 14 states both adding and removing treatments (Table 1). The treatments most commonly added were individual counseling and the nicotine lozenge; the treatments most commonly dropped were group counseling and the nicotine nasal spray During this same period, 38 states made changes to barriers to accessing one or more treatments for at least some plans or populations, with nine states removing barriers without adding new barriers, 12 states adding new barriers without removing existing ones, and 17 states both removing and adding barriers (Table 2). The barriers most commonly removed were copayments, duration limits on treatment, and conditioning access to medications on enrolling in counseling; the barriers most commonly added were prior authorization requirements and annual limits. As of 2014, seven states (
Discussion
Insurance coverage of evidence-based cessation treatments leads to increases in quit attempts, use of cessation treatments, and successful smoking cessation (3). In particular, more comprehensive state
This analysis indicates that although a number of states have added treatments to their state
Several provisions in the 2010 Patient Protection and Affordable Care Act provide opportunities for expanding state
To obtain a full, accurate assessment of a state's
The experience of
The findings in this report are subject to at least four limitations. First, 2014 data were only partially available for
The current status of state
Acknowledgments
What is already known on this topic?
What is added by this report?
Although progress has been achieved in expanding state
What are the implications for public health practice?
States that cover all evidence-based cessation treatments for all
*Additional information available at http://www.healthypeople.gov/2020/ topicsobjectives2020/objectiveslist.aspx?topicid=41.
The tobacco use focus area of Healthy People2020 recendy changed Healthy People 2020objective TU-8 to make the
§ This report assesses state
Î These changes in coverage and barriers were made for at least some plans or populations. Some states made both positive and negative changes to coverage or barriers during the study period. These states are included in both categories.
** Additional information available at http://www.cdc.gov/tobacco/statesystem. Because of slightly different coding rules and categories, as well as different reporting periods, some data presented in this report differ slightly from
[dagger][dagger]Additional information available at http://www.tobaccofreekids.org/press_ releases/post/2012_l l_26_cessation.
§§ Patient Protection and Affordable Care Act of 2010. Pub. L. No. 114-48 (
ÎÎ Additional information available at http://www.medicaid.gov/medicaidchip-program-information/by-topics/benefits/prescription-drugs/ downloads/rx-releases/state-releases/state-rel-165.pdf.
*** The data on state
[dagger][dagger][dagger]In addition to the Affordable Care Act provisions mentioned in this report, this legislation, as written, also provides strong incentives for all states to expand eligibility for
References
1. CDC. Summary health statistics for U.S. adults:
2. Armour BS, Finkeistein EA, Fiebelkorn IC. State-level
3. Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline.
4. CDC. State
5- Land T, Warner D, Paskowsky M, et al.
6. Land T,
7. Richard P, West K,
8. Greene J, Sacks RM, McMenamin SB. The impact of tobacco dependence treatment coverage and copayments in
9. McMenamin SB, Halpin HA, Ganiats TG.
10. McMenamin SB, Halpin HA, Ibrahim JK, et al. Physician and enrollee knowledge of
Jennifer Singleterry, MA1, Zach Jump, MA1, Elizabeth Lancet, MPH1,
(Author affiliations at end of text)
1American
Copyright: | (c) 2014 U.S. Center for Disease Control |
Wordcount: | 2880 |
Pressing Flesh
Trend: Mobile and Messaging GREEN LIGHT ON CLINICIAN-TO-CLINICIAN TEXTING
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News